Piramal Pharma Limited (BOM:543635)
India · Delayed Price · Currency is INR 232.80
+34.35 (17.31%)
At close: Oct 28, 2026
Piramal Pharma Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 97,786 | 88,691 | 91,512 | 81,712 | 70,816 | 67,341 |
Revenue Growth | 9.43% | -3.08% | 11.99% | 15.39% | 5.16% | 14.39% |
Gross Profit Gross Profit Growth | 58,390 | 52,913 | 55,961 | 49,095 | 41,103 | 42,829 |
Operating Income Operating Income Growth | 3,177 | 956.9 | 6,328 | 4,601 | -446.5 | 5,602 |
Net Income Net Income Growth | -2,088 | -3,259 | 911.3 | 178.2 | -1,865 | 3,760 |
Earnings Per Share EPS Growth | -1.57 | -2.46 | 0.68 | 0.14 | -1.57 | 3.19 |
EPS Growth | - | - | 388.86% | - | - | -74.02% |
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 13,019 | 16,622 | 16,632 | 14,445 | 12,256 |
outside India outside India Growth | 75,672 | 74,890 | 65,080 | 56,371 | 53,336 |
Total Total Growth | 88,691 | 91,512 | 81,712 | 70,816 | 65,591 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 8,300 | 13,554 | 4,085 | 5,160 | 6,228 | 2,792 |
Total Debt Total Debt Growth | 58,729 | 57,120 | 48,565 | 47,102 | 56,371 | 41,279 |
Net Cash (Debt) Net Cash Growth | -50,428 | -43,566 | -44,480 | -41,941 | -50,143 | -38,487 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -37.93 | -32.87 | -33.43 | -32.68 | -42.13 | -32.65 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 11,537 | 16,526 | 8,923 | 10,045 | 4,839 | 7,664 |
Capital Expenditures CapEx Growth | -13,155 | -8,900 | -6,644 | -7,120 | -9,648 | -8,895 |
Free Cash Flow Free Cash Flow Growth | -1,618 | 7,626 | 2,279 | 2,925 | -4,809 | -1,231 |
Free Cash Flow Growth | - | 234.58% | -22.08% | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 59.71% | 59.66% | 61.15% | 60.08% | 58.04% | 63.60% |
Operating Margin | 3.25% | 1.08% | 6.92% | 5.63% | -0.63% | 8.32% |
Pretax Margin | 0.24% | -1.99% | 4.53% | 2.19% | -1.70% | 7.20% |
Profit Margin | -2.14% | -3.67% | 1.00% | 0.22% | -2.63% | 5.58% |
FCF Margin | -1.65% | 8.60% | 2.49% | 3.58% | -6.79% | -1.83% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.140 | 0.110 | - | 0.980 |
Dividend Per Share Growth | 27.27% | - | - | - |
Dividend Yield | 0.06% | 0.08% | - | - |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 29, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | 326.96 | 956.95 | - | - |
P/FCF Ratio | - | 23.78 | 130.73 | 58.30 | - | - |
PS Ratio | 3.16 | 2.04 | 3.26 | 2.09 | 1.15 | - |